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stay (28 vs. 20 days, p = 0.145) were similar. Incidence of 
right ventricular failure and tamponade were similar in the 
two groups. Routine DSC after implantation of an LVAD 
did not prove to be beneficial in reducing complications 
associated with coagulopathy and hemodynamic instability 
including cardiac tamponade or right ventricular failure. We 
suggest that DSC be selectively applied for patients undergo-
ing LVAD implant.
Keywords Left ventricular assist device · Delayed sternal 
closure · Right ventricular failure · Vacuum assist device · 
Coagulopathy
Introduction
Bleeding after implantation of a left ventricular assist device 
(LVAD) is common. Reported incidence of reexploration for 
bleeding in this patient population is approximately 30% [1, 
21, 2]. For diffuse bleeding in the mediastinum after surgical 
hemostasis, the sternum may be left open. Delayed sternal 
closure (DSC) may be occasionally adopted for other rea-
sons such as hemodynamic instability, which may be associ-
ated with right ventricular failure in this group of patients 
with chronic heart failure. However, its indications have not 
been clear.
In a recent retrospective study that included 184 patients 
who underwent DSC after LVAD implant, DSC was uti-
lized most commonly for coagulopathy, hemodynamic 
instability and prior sternotomy. DSC was associated with 
longer ICU stay but it was not associated with a significantly 
increased risk of death or infection [3]. In another study 
that analyzed this patient population, DSC was adopted for 
16.8% of those undergoing LVAD with high risk character-
istics including higher use of intraoperative blood products, 
Abstract Delayed sternal closure (DSC) is occasionally 
adopted after implantation of left ventricular assist device 
(LVAD). Recent studies suggest that DSC be used for high 
risk group of patients with coagulopathy, hemodynamic 
instability or right ventricular failure. However, whether 
DSC is efficacious for bleeding complication or right ven-
tricular failure is not known. This study is single center anal-
ysis of 52 patients, who underwent LVAD implantation. Of 
those 52 patients, 40 consecutive patients underwent DSC 
routinely. The sternum was left open with vacuum assist 
device after implantation of LVAD. Perioperative outcome 
of the patients who underwent routine DSC were compared 
with 12 patients who had immediate sternal closure (IC). 
Mean Interagency Registry for Mechanically Assisted Cir-
culatory Support (INTERMACS) level of IC group and DSC 
group were 2.7 and 2.6, respectively. Postoperative bleeding 
(643 vs. 1469 ml, p < 0.001), duration of inotropic support 
(109 vs. 172 h, p = 0.034), and time to extubation (26 vs. 
52 h, p = 0.005) were significantly increased in DSC group. 
Length of ICU stay (14 vs. 15 days, p = 0.234) and hospital 
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longer cardiopulmonary bypass time and right ventricular 
assist device (RVAD) support [4]. DSC may be helpful to 
reduce morbidity and mortality of these high risk patients. 
However, efficacy of DSC, whether DSC reduces bleeding 
complication or right ventricular failure, is not known.
In this study, we made a hypothesis that DSC reduces 
complications associated with coagulopathy and hemody-
namic instability, such as cardiac tamponade or right ven-
tricular failure, for patients undergoing LVAD implantation. 
To determine this hypothesis, we performed DSC with a 
wound vacuum device routinely after LVAD implant and 
closed the chest the following day. The occurrence of bleed-
ing complications, cardiac tamponade, or right ventricular 
failure was retrospectively reviewed. The patients with DSC 
were compared with those with immediate closure (IC).
Methods
From May 2008 to October 2012, 52 patients underwent 
insertion of HeartMate II LVAD (Thoratec Corp., Pleasan-
ton, CA) at our institution. First 12 patients had the chest 
closed at the initial operation (IC group, n = 12). Thereaf-
ter, 40 patients underwent routine DSC with wound vacuum 
device (DSC group, n = 40). All patients enrolled in this 
study have given their informed consent, which has been 
approved by the institutional committee and this protocol 
has been found acceptable by them.
DSC was performed as the following. After insertion 
of an LVAD, hemostasis was done and 32 Fr. chest tubes 
were placed in the mediastinum inferior and anterior to the 
ventricle. The chest was temporarily closed with wound 
vacuum device (Kinetic Concepts Inc., San Antonio, TX). 
A  WhiteFoam® dressing was placed on the anterior wall of 
the right ventricle. A black  Simplace® dressing was placed 
above the  WhiteFoam® dressing to fill the space between 
the sternal edge and the skin level. A thin plastic drape was 
placed on the chest and continuous vacuum was started at 
25–50 mmHg depending on the amount of bleeding and 
chest tube output [5]. Chest tubes were placed on suction 
at 20 cmH2O.
Postoperatively continuous intravenous infusion of propo-
fol (0.01–0.05 mg/kg/min) was used to lightly sedate the 
patient after recovery of consciousness and gross neurologic 
examination. Inotropes and vasopressors regimen included 
epinephrine, norepinephrine and milrinone, and were titrated 
to maintain mean arterial pressure above 60 mmHg and 
adequate urine output. Nitric oxide, started at 20 parts per 
million, was used when there were signs of right ventricular 
dysfunction including elevation of central venous pressure 
greater than 15 mmHg or echocardiographic finding of right 
ventricular dysfunction. On postoperative day 1 the chest 
was closed in the operating room in the standard fashion. 
All the mediastinal clots were removed. The patients were 
mobilized from the bed several hours after extubation. Post-
operative antibiotics included vancomycin and rifampin and 
piperacillin/tazobactam for 3 days. For patients with penicil-
lin allergy, cefepime instead of piperacillin/tazobactam was 
given for 3 days.
Continuous variables were summarized by mean ± stand-
ard deviation. Normally distributed continuous variables 
were compared across two groups by the independent 
samples t test. Non-normally distributed variables were 
compared across two groups by the Wilcoxon rank sum 
test. Categorical variables were summarized by frequency 
and percent. Categorical variables were compared across 
groups by the Fisher’s exact test. A p value < 0.05 was con-
sidered significant. SPSS™ statistical software version 20 
(IBM Corporation, New York, NY) was used for statistical 
analysis.
Results
Baseline clinical characteristics of the study patients are 
shown in Table 1. INTERMACS profile level was similar 
in two groups. Twelve patients (25%) were supported by 
mechanical circulatory support before an LVAD insertion 
in the study patients, 2 in IC and 10 in DSC. Pre-LVAD 
mechanical circulatory support included veno-arterial extra-
corporeal membranous oxygenation for 3 patients, intra-
aortic balloon pump (IABP) for 3, HeartMate I (Thoratec 
Corp.) for 1, biventricular support with CentriMag (Thoratec 
Table 1  Baseline clinical characteristics
BMI body mass index, BSA body surface area, BTT bridge to trans-
plant, DSC delayed sternal closure group, DT destination therapy, IC 
immediate sternal closure group, INTERMACS Interagency Registry 
for Mechanically Assisted Circulatory Support, LVAD left ventricular 
assist device
All (n = 52) IC (n = 12) DSC (n = 40) p
Age (years) 54.4 ± 12.7 59.4 ± 11.5 52.9 ± 12.8 0.119
Female 14 (27%) 2 (17%) 12 (30%) 0.475
BSA  (m2) 2.1 ± 0.3 2.2 ± 0.3 2.1 ± 0.2 0.407
BMI (kg/m2) 30.1 ± 6.5 32.2 ± 7.4 30.3 ± 6.3 0.385
Mean INTERMACS 
level
3 2.7 2.6 N/A
Previous sternotomy 15 (29%) 2 (18%) 13 (33%) 0.472
Bridging device to 
LVAD
12 (23%) 2 (18%) 10 (25%) 0.706
Mechanical ventila-
tion
7 (13.5%) 1 (9.1%) 6 (15%) 1.000
Inotropes 21 (41%) 6 (55%) 15 (38%) 0.327
Ischemic cardio-
myopathy
36 (69%) 6 (50%) 30 (75%) 0.153
DT (vs. BTT) 23 (44%) 4 (33%) 19 (48%) 0.153
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Corp.) for 1, CentriMag LVAD with IABP for 1, CentriMag 
right ventricular assist device (RVAD) with IABP for 1, 
CentriMag RVAD for 1 and Impella 5.0 (Abiomed, Dan-
vers, MA) for 1.
Preoperative laboratory data and hemodynamics are 
shown in Tables 2 and 3, respectively. No significant differ-
ence was identified between the two groups.
Postoperative outcome is summarized in Table 4. Opera-
tion time was similar in the two groups. Concomitant sur-
gery was performed in 10 patients (19%), 3 (25%) in IC 
and 7 (18%) in DSC, including 4 RVADs, 4 tricuspid valve 
repairs, 3 aortic valve replacements, 1 atrial septal defect and 
1 patent foramen ovale closure. Use of factor VII was more 
common in DSC (p = 0.02). Postoperative bleeding, duration 
of inotropic support and time to extubation were signifi-
cantly increased in DSC. Length of ICU stay and hospital 
stay were similar in the two groups. There was no sternal 
infection in either group. 30 day and 1 year survival were 
similar in the two groups.
Total direct cost per case excluding provider tax is shown 
in Table 5. The cost was similar in the two groups. Costs for 
surgery and anesthesia were greater in DSC but nursing ICU 
cost was lower in DSC.
Discussion
The present study reviewed outcome of patients who under-
went DSC after implantation of LVAD. DSC did not reduce 
Table 2  Preoperative laboratory data
AST aspartate aminotransferase, Bil bilirubin, Cr creatinine, DSC 
delayed sternal closure group, Hb hemoglobin, IC immediate sternal 
closure group, INR international normalized ratio, Plt platelet
All (n = 52) IC (n = 12) DSC (n = 40) p
Serum Cr (mg/dL) 1.5  ± 0.6 1.7  ± 0.8 1.4 ± 0.5 0.132
Total Bil. (mg/dL) 2.1 ± 2.9 1.4 ± 1.3 2.3 ± 3.2 0.385
AST (U/L) 134 ± 486 32 ± 23 162 ± 547 0.438
Albumin (g/dL) 3.1 ± 0.6 3.0 ± 0.7 3.1 ± 0.5 0.524
Hb (g/dL) 11.3 ± 2.5 10.6 ± 1.9 11.4 ± 2.6 0.302
Plt (k/μL) 197 ± 113 230 ± 194 188 ± 79 0.502
INR 1.8 ± 1.1 1.8 ± 0.7 1.7 ± 1.2 0.964
Table 3  Preoperative hemodynamics
BP blood pressure, CI cardiac index, CVP central venous pressure, 
HR heart rate, mAP mean arterial pressure, mPAP mean pulmonary 
arterial pressure, PCWP pulmonary capillary wedge pressure
All (n = 52) IC (n = 12) DSC (n = 40) p
HR (/min) 86 ± 22 83 ± 29 92 ± 21 0.274
Systolic BP 
(mmHg)
100 ± 19 96 ± 13 102 ± 18 0.290
Diastolic BP 
(mmHg)
59  ± 15 63 ± 14 56 ± 11 0.147
CI (l/min/m2) 2.0 ± 0.4 2.1 ± 0.6 1.8  ± 0.3 0.052
CVP (mmHg) 19 ± 7 19 ± 6 19 ± 7 0.892
PCWP (mmHg) 30 ± 8 29 ± 8 30 ± 7 0.793
mPAP (mmHg) 43  ± 12 44  ± 11 43 ± 12 0.793
Table 4  Postoperative clinical 
characteristics
CPB cardiopulmonary bypass, DSC delayed sternal closure group, IC immediate sternal closure group, 
ICU intensive care unit, LOS length of stay, OR operating room, PRBC packed red blood cell, RV right 
ventricle
All (n = 52) IC (n = 12) DSC (n = 40) p
OR time (min) 321 ± 115 332 ± 135 318 ± 110 0.753
CPB time (min) 111 ± 51 92 ± 22 115 ± 55 0.322
Concomitant surgery 10 (19%) 3 (25%) 7 (18%) 0.669
Use of factor VII 16 (31%) 0 16 (41%) 0.020
Postoperative bleeding in the first 
24 h (ml)
1278 ± 944 643 ± 300 1469 ± 989 < 0.001
Postoperative PRBC (unit) 3.3 ± 1.2 3.3 ± 1.0 3.2 ± 1.3 0.564
Reexploration for bleeding 2 (4%) 1 (8%) 1 (3%) 0.412
Cardiac tamponade 3 (6%) 1 (8%) 2 (5%) 0.553
RV failure 6 (12%) 0 6 (15%) 0.316
Sternal infection 0 0 0 N/A
Driveline infection 5 (10%) 2 (17%) 3 (8%) 0.325
Inotropic support (h) 158 ± 90 109 ± 70 172 ± 91 0.034
Time to extubation (h) 46 ± 42 26 ± 23 52 ± 45 0.005
ICU stay (days) 15 ± 16 14 ± 8 15 ± 18 0.234
LOS (days) 22 ± 17 28 ± 19 20 ± 17 0.145
30 day survival (%) 90 92 90 1.000
1 year survival (%) 74 83 70 0.693
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incidence of bleeding complications, cardiac tamponade 
or right ventricular failure compared to IC. DSC increased 
postoperative bleeding, time to extubation but not length of 
stay in ICU. Objective of our study was different from other 
retrospective studies in which DSC were selectively applied. 
Contrary to those studies which identified risk factors that 
required DSC, our study attempted to determine efficacy 
of DSC.
The sternum may be left open after implantation of LVAD 
[2–4]. DSC may be adopted for reasons including bleed-
ing, hemodynamic instability, right ventricular failure and 
arrhythmia. When it is done for bleeding, theoretical ben-
efit may include less occurrence of cardiac tamponade by 
providing more pericardial space. It also provides benefit 
of immediate access for mediastinal exploration if needed 
in the ICU for acute change in hemodynamics. Bleeding in 
patients with DSC was approximately 820 ml greater than 
in patients with IC in the first 24 h in the present study. 
Persistent bleeding was frequently noticed from the vacuum 
assist device while there was minimal bleeding from the 
mediastinal chest tubes. Vacuum assist device was occasion-
ally sucking blood from the bone marrow of the sternum 
since the negative pressure applied by the vacuum assist 
device was greater than negative pressure applied by 32 Fr. 
chest tubes in the mediastinum. In a case study that reported 
use of wound vacuum assisted closure to control coagulo-
pathic bleeding in a patient after insertion of LVAD, it was 
theorized that a tamponade effect between the mediastinal 
tissue and surgical sponges is established by the negative 
pressure applied by the chest tubes placed in pleural cavities 
bilaterally [6]. In our experience, negative pressure could 
not be applied effectively on the entire mediastinum due to 
communication with chest tubes and blood loss appeared 
to be greater due to bleeding from the sternum. Amount of 
blood transfusion was similar in both groups. This may be 
explained by our practice of restrictive strategy and minimiz-
ing amount of blood transfusion to prevent immunomodula-
tion effect for potential future transplant.
We did not observe significant difference in the incidence 
of right ventricular failure in two groups of patients regard-
less of the sternum was left open or closed at the time of 
LVAD implantation; none in IC and 6 patients (15%) in DSC 
(p = 0.316). Sternal closure has been shown to result in a sig-
nificant decrease in cardiac output and diastolic filling even 
in patients with good cardiac performance [7]. Furnary et al. 
has demonstrated that low cardiac output can be improved 
by the opening of the sternum [8]. With this evidence one 
may think that leaving the chest open would help prevent 
right ventricular failure potentially precipitated by sternal 
closure. Right ventricular failure can occur at any time after 
insertion of LVAD. Most of RVAD insertion after LVAD 
implant occurs in the operating room at the time of LVAD 
insertion or within 24 h [9]. In our group of patients with 
DSC it was possible that right ventricle, which would have 
developed right ventricular failure recovered in the first 24 h 
while the chest was open. However, owing to the retrospec-
tive nature of the study, our results do not provide more 
insight into this issue.
No patients had sternal infection regardless of timing 
of chest closure in the current study. DSC as a risk factor 
for sternal infection has been debated [10, 11]. In a recent 
study that included 5177 patients who underwent cardiac 
procedures, 87 patients (1.7%) were managed with DSC. 
Incidence of sternal infection was 4.6%. Redo operations, 
insertion of VAD, tracheostomy and prolonged open chest 
were potential risk factors for sternal infection [11]. On the 
other hand, more recently in patients after LVAD implanta-
tion, Stulak et al. reported that there was no increase in the 
incidence of infectious complication in 184 patients who 
had DSC after LVAD implantation [3]. Results in our study 
support this finding. Although further studies with more 
patients are needed to conclude, DSC can be safely applied 
for patients implanted with a VAD without increasing sternal 
infectious complications.
In the present study, DSC prolonged time to extubation 
since the patients stayed intubated until the chest was closed 
the following day. For the same reason DSC prolonged the 
use of IV inotropes since weaning of inotropes usually 
started after the sternum was closed. It was expected that 
this would lead to longer ICU stay in patients after DSC; 
however, there was no difference between the two groups. 
To minimize ICU stay early extubation and ambulation were 
encouraged. Early ambulation, which is 4 to 6 h after extu-
bation, was still possible in patients after DSC. There was 
Table 5  Total cost per case 
for implantation of LVAD 
(excluding provider tax)
DSC delayed sternal closure group, IC immediate sternal closure group, ICU intensive care unit, $ dollars
IC DSC
Period (year) 2008–2010 2011–2012
Total ($, range) 195,171 (189,142–204,053) 188,644 (182,357–194,430)
Surgery ($, range) 107,706 (96,294–121,002) 131,601 (128,086–135,117)
Anesthesia ($, range) 4155 (3338–4608) 4249 (3692–4085)
Nursing ICU ($, range) 33,155 (27,300–41,842) 17,749 (14,033–21,465)
Pharmacy ($, range) 13,556 (10,171–19,807) 8679 (6719–10,639)
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no difference in overall cost for hospital admission in two 
groups. It was attributed to early mobilization in the postop-
erative management of patients after DSC. At the same time 
management of LVAD patients in the ICU became more 
efficient as more VAD implantations were performed.
Our study did not prove routine DSC to be advantageous 
and suggests that DSC be selectively applied. Question 
remains in terms of which patients should have DSC after 
implantation of LVAD. There are patients who continue to 
bleed after insertion of LVAD, especially in patients with 
previous sternotomy or on platelet inhibitors. These bleed-
ing patients with cardiomyopathy are susceptible to hemo-
dynamic instability and threshold to reexploration should 
be low. Although DSC was not found useful to decrease the 
incidence of cardiac tamponade or right ventricular failure 
in our experience, there is still an added advantage of allow-
ing immediate access to the mediastinum for evacuation of 
blood and clots for cardiac tamponade and for application of 
internal defibrillation if needed in ICU. In studies that ana-
lyzed patients in whom DSC was adopted after LVAD inser-
tion, indication was mainly for coagulopathy. Two recent 
studies described use of DSC in this patient population [3, 
4]. In Stulak’s study, reasons for DSC included coagulopa-
thy in 155 patients (84%), hemodynamic instability in 103 
(56%), significant isolated right ventricular dysfunction in 
15 (8%). The other study that analyzed use of DSC after 
LVAD implant did not mention reason for DSC but identi-
fied predictors of DSC including preoperative glycoprotein 
IIb/IIIa inhibitor, more intraoperative use of PRBC and 
tricuspid valve procedure [4]. For coagulopathic patients 
DSC actually increases bleeding but facilitates subsequent 
reexploration. For patients with tenuous right ventricular 
function DSC will be needed if the patient does not tolerate 
sternal approximation, however, DSC itself will not reduce 
incidence of postoperative right ventricular dysfunction.
Limitations
Our case series is limited by a small number of patients and 
retrospective assessment of data and it is subject to all limi-
tations inherent in such studies. In this observational study, 
sample sizes of patients with DSC and IC were not balanced. 
This sample size imbalance was partly due to increasing case 
volume during the study period as the number of referrals to 
our mechanical circulatory support program increased. DSC 
was introduced to our practice as the program was increas-
ing case volume. As case volume increased the patients who 
needed LVAD became more heterogeneous, although two 
groups are statistically similar in collected variables. Lack 
of balance in sample size may make finding a significant 
difference more difficult. Failure to detect a difference may 
be a result of low power due to small sample size. Brain 
natriuretic peptide measurement was not routinely done 
early in the study period and was not shown in this study. 
Echocardiographic finding was not shown in this study since 
diagnosis of right ventricular failure after VAD implantation 
was made clinically including hemodynamic data. From our 
visual observation, increase in blood loss in DSC was attrib-
uted to continuous marrow bleed from the sternum; however, 
blood loss was measured as a combined output from the 
wound vacuum device and the chest tubes. Separate meas-
urement of two drainage sources was not performed in this 
study. To more strictly compare the amount of bleeding, all 
the blood products given for bleeding should be measured. 
In our study, only the amount of packed red blood cell and 
factor VII were included as parameters.
Conclusions
Routine DSC after implantation of an LVAD did not prove 
to be beneficial in reducing complications associated with 
coagulopathy and hemodynamic instability including car-
diac tamponade or right ventricular failure. Although it 
increased postoperative bleeding and time to extubation, it 
did not increase hospital length of stay, incidence of ster-
nal infection or driveline infection. We suggest that DSC be 
selectively applied for patients undergoing LVAD implant.
Compliance with ethical standards 
Conflict of interest The authors declare that they have no conflict 
of interest.
Open Access This article is distributed under the terms of the 
Creative Commons Attribution 4.0 International License (http://crea-
tivecommons.org/licenses/by/4.0/), which permits unrestricted use, 
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to 
the Creative Commons license, and indicate if changes were made.
References
 1. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, 
Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, 
Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II 
Investigators. Advanced heart failure treated with continuous-flow 
left ventricular assist device. N Engl J Med. 2009;361:2241–51.
 2. Schaffer JM, Arnaoutakis GJ, Allen JG, Weiss ES, Patel ND, Rus-
sell SD, Shah AS, Conte JV. Bleeding complications and blood 
product utilization with left ventricular assist device implantation. 
Ann Thorac Surg. 2011;91:740–7.
 3. Stulak JM, Romans T, Cowger J, Romano MA, Haft JW, Aaronson 
KD, Pagani FD. Delayed sternal closure does not increase late 
infection risk in patients undergoing left ventricular assist device 
implantation. J Heart Lung Transplant. 2012;31:1115–9.
51J Artif Organs (2018) 21:46–51 
1 3
 4. Quader M, LaPar DJ, Wolfe L, Ailawadi G, Rich J, Speir A, Fon-
ner C, Kasirajan V; Investigators for the Virginia Cardiac Surgery 
Quality Initiative. Delayed sternal closure after continuous flow 
left ventricle assist device implantation: analysis of risk factors 
and impact on outcomes and costs. ASAIO J. 2016;62:432–7.
 5. Fleck T, Kickinger B, Moidl R, Waldenberger F, Wolner E, Gra-
benwoger M, Wisser W. Management of open chest and delayed 
sternal closure with the vacuum assisted closure system: prelimi-
nary experience. Interact Cardiovasc Thorac Surg. 2008;7:801–4.
 6. Sjögren J, Gustafsson R, Koul B, Ingemansson R. Selective medi-
astinal tamponade to control coagulopathic bleeding. Ann Thorac 
Surg. 2003;75:1311–3.
 7. Matsumoto M, Oka Y, Strom J, Frishman W, Kadish A, Becker 
RM, Frater RW, Sonnenblick EH. Application of transesophageal 
echocardiography to continuous intraoperative monitoring of left 
ventricular performance. Am J Cardiol. 1980;46:95–105.
 8. Furnary AP, Magovern JA, Simpson KA, Magovern GJ. Pro-
longed open sternotomy and delayed sternal closure after cardiac 
operations. Ann Thorac Surg. 1992;54:233–9.
 9. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller 
LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, 
Farrar DJ; HeartMate II Clinical Investigators. Right ventricu-
lar failure in patients with the HeartMate II continuous-flow left 
ventricular assist device: incidence, risk factors, and effect on 
outcomes. J Thorac Cardiovasc Surg. 2010;139:1316–24.
 10. Anderson CA, Filsoufi F, Aklog L, Farivar RS, Byrne JG, Adams 
DH. Liberal use of delayed sternal closure for postcardiotomy 
hemodynamic instability. Ann Thorac Surg. 2002;73:1484–8.
 11. Boeken U, Assmann A, Mehdiani A, Akhyari P, Lichtenberg 
A. Open chest management after cardiac operations: outcome 
and timing of delayed sternal closure. Eur J Cardiothorac Surg. 
2011;40:1146–50.
